DIVI S LABORATORIES LTD DCF Valuation

DIVISLAB · Healthcare · Current price ₹7,247.5

Full stock page
DocStoX fair value
₹1,561
low confidence
Intrinsic-value estimate
₹770
17% ROE fading to 12% over ~10 yrs, on ₹631 book
Current price
₹7,248
Economic moat
Narrow
Medium uncertainty
5Y profit growth
+5.3%
Model it yourself — DCF Calculator
Opens pre-filled with DIVI S LABORATORIES LTD's latest numbers.

DIVI S LABORATORIES LTD intrinsic-value estimate

Our intrinsic-value model estimates DIVI S LABORATORIES LTD is worth ₹770 per share, based on 17% ROE fading to 12% over ~10 yrs, on ₹631 book. Rather than a raw DCF — which is highly sensitive to fragile cash-flow forecasts — we use a residual-income (excess-return) model: a company is worth its book value plus the present value of the returns it earns ABOVE its cost of equity. A narrow economic moat sets how long that edge is assumed to last.

Try your own assumptions

Prefer a classic discounted-cash-flow view? Open the DCF calculator below — it pre-fills DIVI S LABORATORIES LTD's real free cash flow, net debt and share count so you can model your own growth and discount-rate scenario in seconds.

More on DIVI S LABORATORIES LTD

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.